TJ Biotech Holding ApS — Credit Rating and Financial Key Figures
CVR number: 41953616
Pile Alle 20, Øverød 2840 Holte
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 416.05 | 1 749.11 | 53.54 | 70.00 | 118.22 |
| Employee benefit expenses | -1 343.74 | -1 345.77 | -63.78 | -70.02 | -68.59 |
| EBIT | 72.31 | 403.34 | -10.24 | -0.01 | 49.64 |
| Other financial income | 62.15 | 181.76 | 88.70 | 288.00 | 1 051.46 |
| Other financial expenses | -14.26 | -22.44 | - 294.24 | -1 151.52 | -82.36 |
| Net income from associates (fin.) | -8 650.00 | - 342.79 | |||
| Pre-tax profit | 120.20 | 562.67 | - 215.77 | -9 513.53 | 675.94 |
| Income taxes | -30.00 | - 150.00 | -8.20 | ||
| Net earnings | 90.20 | 412.67 | - 215.77 | -9 513.53 | 667.74 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 10 936.60 | 11 034.02 | 11 034.02 | 1 749.71 | 289.71 |
| Investments total | 10 936.60 | 11 034.02 | 11 034.02 | 1 749.71 | 289.71 |
| Non-curr. owed by particip. interest comp. | 82.79 | 134.14 | |||
| Non-current loans receivable | 10 443.00 | 10 943.80 | 10 993.80 | 11 343.63 | 11 727.06 |
| Long term receivables total | 10 443.00 | 10 943.80 | 10 993.80 | 11 426.42 | 11 861.20 |
| Inventories total | |||||
| Current trade debtors | 245.00 | 546.75 | 37.50 | 112.50 | |
| Current owed by particip. interest comp. | 97.43 | ||||
| Current other receivables | 501.95 | 619.94 | 914.19 | 369.85 | 139.26 |
| Current deferred tax assets | 24.53 | 48.04 | 26.04 | ||
| Short term receivables total | 844.38 | 1 166.69 | 938.71 | 455.40 | 277.79 |
| Other current investments | 892.19 | 1 205.23 | 705.98 | 4 335.07 | 6 398.52 |
| Cash and bank deposits | 533.38 | 159.67 | 58.58 | 173.88 | 119.63 |
| Cash and cash equivalents | 1 425.57 | 1 364.89 | 764.57 | 4 508.95 | 6 518.15 |
| Balance sheet total (assets) | 23 649.55 | 24 509.41 | 23 731.10 | 18 140.48 | 18 946.85 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 22 941.27 | 23 031.46 | 23 444.13 | 23 228.36 | 13 714.83 |
| Profit of the financial year | 90.20 | 412.67 | - 215.77 | -9 513.53 | 667.74 |
| Shareholders equity total | 23 071.46 | 23 484.13 | 23 268.36 | 13 754.83 | 14 422.57 |
| Non-current deferred tax liabilities | 4 040.00 | 4 197.35 | |||
| Non-current liabilities total | 4 040.00 | 4 197.35 | |||
| Current trade creditors | 20.00 | 36.83 | 25.00 | 25.00 | 25.00 |
| Current owed to participating | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
| Short-term deferred tax liabilities | 14.26 | 150.00 | |||
| Other non-interest bearing current liabilities | 537.27 | 831.89 | 431.19 | 314.10 | 295.38 |
| Current liabilities total | 578.08 | 1 025.28 | 462.74 | 345.65 | 326.94 |
| Balance sheet total (liabilities) | 23 649.55 | 24 509.41 | 23 731.10 | 18 140.48 | 18 946.85 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.